Corporate governance
We are fully committed to good corporate governance. Our principles and rules on corporate governance are laid down in the articles of association and the organizational regulations, among other documents.
2026
2025
2024
2023
The Annual General Meeting took place on 7 May 2026, in Kaiseraugst, Switzerland.
Annual General Meetings (EN)
Annual General Meetings (DE)
Annual General Meetings (NL)
Annual General Meetings (FR)
The Annual General Meeting took place on 6 May 2025, in Kaiseraugst, Switzerland.
Annual General Meetings (EN)
Annual General Meetings (DE)
Annual General Meetings (NL)
Annual General Meetings (FR)
Articles of Association (with proposed changes)
The Annual General Meeting of DSM-Firmenich AG took place on 7 May 2024 at the company’s head offices at Wurmisberg 576, 4303 Kaiseraugst, Switzerland. All resolutions on the agenda were approved by the shareholders.
Annual General Meetings (EN)
Annual General Meetings (DE)
Annual General Meetings (NL)
Annual General Meetings (FR)
The extraordinary general meeting of shareholders was held on June 29, 2023 at the company offices at Wurmisweg 576, 4303 Kaiseraugst, Switzerland. All resolutions on the agenda were approved by the shareholders.
The shareholders or shareholder representatives voted on 197,464,498 shares or 74.45% of the issued share capital entitled to vote. Number of votes per share is 1 and the number of outstanding shares on 29 June 2023, the date of the meeting, was 265,217,171.
EGM (EN)
EGM (DE)
EGM (NL)
EGM (FR)
Interim Financial Statements
Remuneration at dsm-firmenich
Statement on BoD and Exco remuneration (ENG)
Statement on BoD and Exco remuneration (NL)
Articles of association (with proposed amendments highlighted)
Article of association (with proposed amendments)
Approval of the stand-alone interim financial statements of DSM-Firmenich AG for the period from 1 January 2023 to 8 May 2023
| For | Against | Abstain | Total | |
| Votes | 195,384,208 | 1,200,493 | 879,797 | 197,464,498 |
| % | 98.95% | 0.61% | 0.45% |
Dividend / Distribution of Capital Contribution Reserves
| For | Against | Abstain | Total | |
| Votes | 197,445,780 | 8,293 | 10,425 | 197,464,498 |
| % | 99.99% | 0.00% | 0.01% |
Approval of remuneration for the Board of Directors
| For | Against | Abstain | Total | |
| Votes | 195,384,208 | 4,485,119 | 1,076,031 | 197,464,498 |
| % | 97.18% | 2.27% | 0.54% |
Approval of the remuneration of the Executive Committee
| For | Against | Abstain | Total | |
| Votes | 191,489,400 | 4,476,258 | 1,498,840 | 197,464,498 |
| % | 96.97% | 2.27% | 0.76% |
Approval of certain important transactions by shareholders
| For | Against | Abstain | Total | |
| Votes | 185,937,469 | 3,530,633 | 7,996,396 | 97,464,498 |
| % | 94.16% | 1.79% | 4.05% |
Possibility of the Board of Directors to request custodians to disclose the identity of shareholders and beneficial owners
| For | Against | Abstain | Total | |
| Votes | 184,157,906 | 3,790,079 | 9,516,513 | 197,464,498 |
| % | 93.26% | 1.92% | 4.82% |
Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.
We are fully committed to good corporate governance. Our principles and rules on corporate governance are laid down in the articles of association and the organizational regulations, among other documents.
Sustainability is fundamental to how dsm-firmenich brings progress to life – for people and planet.
Through science and innovation, we are creating a world of potential for investors.
Be the first to know about key news as we continue shaping the future and bringing progress to life.